2002
DOI: 10.1081/ddc-120001485
|View full text |Cite
|
Sign up to set email alerts
|

Preparation and Characterization of Coenzyme Q10–Eudragit® Solid Dispersion

Abstract: A solid dispersion of Coenzyme Q10 and Eudragit L 100-55 was prepared using solvent evaporation method. Solid dispersion, physical mixture, and pure compound were then characterized using differential scanning calorimetry and powder x-ray diffraction. Solubility of CoQ10 in different surfactant media was measured, and a suitable dissolution medium was developed to compare the dissolution patterns of the solid dispersion, physical mixture, and the pure compound. Combining labrasol with different surfactants in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
31
0

Year Published

2003
2003
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 58 publications
(31 citation statements)
references
References 20 publications
0
31
0
Order By: Relevance
“…Capryol 90 was used as the oil phase, mixture of Labrasol and Tween 20 as the surfactant and Transcutol P as the co-surfactant. Phase diagrams were constructed by a technique well described (Kommuru et al 2001;Nazzal et al 2002;Taha et al 2004) with ratios as mentioned in Table 1 and all preparations were diluted 100 times with 0.1 N HCl. For each phase diagram at specific oil:S mix ratios (1:9, 1:6 and 1:4), mixtures of the oil, the surfactant and the co-surfactant were prepared, and the mixture was diluted with 0.1 N HCl, maintained at 37°C.…”
Section: Pseudo-ternary Phase Diagrammentioning
confidence: 99%
“…Capryol 90 was used as the oil phase, mixture of Labrasol and Tween 20 as the surfactant and Transcutol P as the co-surfactant. Phase diagrams were constructed by a technique well described (Kommuru et al 2001;Nazzal et al 2002;Taha et al 2004) with ratios as mentioned in Table 1 and all preparations were diluted 100 times with 0.1 N HCl. For each phase diagram at specific oil:S mix ratios (1:9, 1:6 and 1:4), mixtures of the oil, the surfactant and the co-surfactant were prepared, and the mixture was diluted with 0.1 N HCl, maintained at 37°C.…”
Section: Pseudo-ternary Phase Diagrammentioning
confidence: 99%
“…The formulation was claimed to be stable, however, it was found that the solubility of CoQ 10 was not much enhanced. A SD of CoQ 10 prepared with Eudragit ® L100-55 was reported in literature which exhibited 100% release of CoQ 10 in dissolution test (Nazzal et al, 2002a). However, the work employed an aqueous dissolution medium comprising 4% Labrasol and 2% Cremophor ® EL which altered the dissolution value significantly.…”
Section: Introductionmentioning
confidence: 96%
“…In these drugs, dissolution of the drug is the rate limiting step in the absorption process. To triumph over these obstacles, numbers of formulation approaches are reported including the use of surfactants (Allaboun et al, 2003;Balakrishnan et al, 2004;Chakraborty et al, 2009), lipids (Yeap et al, 2013), permeation enhancers (Burcin et al, 2010;Beg et al, 2011), formation of salt (Li et al, 2005;Serajuddin, 2007), co-crystallization (Shan & Zaworotko, 2008;Qiao et al, 2011;Chadha et al, 2012), solid dispersions (Serajuddin, 1999), inclusion complexes with cyclodextrins and modified cyclodextrins (Miyake et al, 2000;Veiga et al, 2000;Wang et al, 2000;Bannwart et al, 2001;Carrier et al, 2007;Gamsiz et al, 2010a,b;Gamsiz et al, 2011;Badr-Eldin et al, 2008;Kumar et al, 2013), nanosuspensions (Patravale et al, 2004), and colloidal vesicles like liposomes (Nazzal et al, 2002a;Manconi et al, 2013;Yang et al, 2013), and niosomes (Khazaeli et al, 2007;Bayindir & Yuksel, 2010;SezginBayindir et al, 2013;Jin et al, 2013) In modern years, self-nanoemulsifying drug delivery systems (SNEDDS) are the most popular and commercially feasible lipid-based formulation approach for improving oral bioavailability of poorly water soluble and lipophilic drugs (Pouton, 2006;Date, 2007;Shweta et al, 2011). SNEDDS are precisely defined as an isotropic multi-component drug delivery systems composed of a synthetic or natural oil, surfactant, and co-surfactant that have a unique ability of forming fine oil in water micro-or nano-emulsion upon mild agitation followed by dilutio...…”
Section: Introductionmentioning
confidence: 99%